Nuohui Health starts with bowel cancer and wants to eradicate cancer through early screening

For cancer prevention and control systems, the medical community recognizes four layers: healthy living, early diagnosis and treatment, effective treatment, and maximizing the quality of life of patients. The corresponding effective rate of prevention and control is close to 35%, 53%, 12% and 0%. It can be seen that early screening is very important.

Nuohui Health is an innovative bio-tech company focused on the development of early detection technologies and testing services for high-risk cancers in China to achieve the goal of completely eradicating cancer.

Nuohui Health has developed a screening product for the characteristics of Chinese colon cancer - Chang Weiqing, a non-invasive, painless, non-invasive, and home-based genetic testing technology: by analyzing genetic material in feces (Fecal DNA), Chang Weiqing can detect advanced adenomas and intestinal cancer lesions with a diameter of more than 1 cm, and detect early intestinal cancer gene mutations, so that intestinal cancer is found 5 years earlier than the hospital diagnosis.

Zhuo Ye, CEO of Nuohui Health, revealed that early screening products for gastric cancer will be introduced at the end of this year, and then extended to other digestive tract cancers such as esophageal cancer, pancreatic cancer, etc., followed by respiratory-related cancers such as lung cancer. There are several main reasons why colon cancer is the starting point:

The incidence and deaths were high, accounting for 18.6% and 20.1% of the total number of cases of morbidity and mortality worldwide, respectively, ranking first.

The onset period is long, from early lesions to late deaths for more than 10 years.

The early screening method for bowel cancer is relatively simple, and colonoscopy can be performed.

Polyps and adenomas after diagnosis can be completely cured by minimally invasive surgery.

There are no early symptoms of bowel cancer. Even if there is blood in the stool in the late stage, people usually think that it is hemorrhoids and will not attract attention. People pay more attention to cancer for women with two cancers (breast cancer and cervical cancer), because their propaganda reports such as celebrity endorsements and more. In this respect, the field of intestinal cancer is also a blue ocean.

When it comes to colonoscopy, Zhu Yeqing introduced that due to its invasive (colonoscopy needs to be inserted into the intestine), pain, complicated procedures (registration, queuing, medical treatment, etc.) and high costs, the penetration rate of colonoscopy in urban areas of China is only 1 %~2%. Therefore, Nuohui Health has developed Chang Weiqing, a simpler method of screening for colon cancer than colonoscopy.

N95-Face Mask Niosh Approved N95 FDA Clear Surgical Mask

N95

Dongguan Keyutai Mask Co., Ltd. , https://www.maskkytai.com